← FDA Drug Approvals (Drugs@FDA)

DOCOSANOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KLM LABS PVT · Approved 2026-07-31

Drug application

FDA Application #
ANDA220017
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOCOSANOL
Generic name
Docosanol
Active ingredients
DOCOSANOL
Dosage form
CREAM
Route
TOPICAL
Marketing status
Over-the-counter
Sponsor
KLM LABS PVT
First approval
2026-07-31

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown